Randall Hearne
Adult Health · Perry, FLNPI 1831184910
Payments from drug & device makers
Across 236 payments — averaging $14.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$788
- Bayer$444
- Lilly USA, LLC$326
- GSK$228
- Sanofi-aventis U.S. LLC$203
- Pfizer$152
- plus $1K from 27 others
What the payments were for
- Food & beverage$3,535100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 47 | $788 |
| Bayer | 32 | $444 |
| Lilly USA, LLC | 21 | $326 |
| GSK | 24 | $228 |
| Sanofi-aventis U.S. LLC | 10 | $203 |
| Pfizer | 10 | $152 |
| AstraZeneca | 11 | $149 |
| AbbVie | 9 | $144 |
| Eisai Inc. | 9 | $134 |
| Novartis | 11 | $128 |
| Boehringer Ingelheim | 6 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $97 |
| Amgen | 5 | $71 |
| Dexcom, Inc. | 3 | $55 |
| Kowa Pharmaceuticals America, Inc. | 4 | $54 |
| Jazz Pharmaceuticals Inc. | 3 | $48 |
| Exact Sciences | 3 | $47 |
| Merck | 3 | $43 |
| Johnson & Johnson | 3 | $39 |
| Amarin Pharma, Inc. | 2 | $37 |
| Corcept Therapeutics | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 2 | $23 |
| Corium, LLC | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Abbott | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
| PBG Puerto Rico LLC | 1 | $12 |
| Nestle Healthcare Nutrition Inc. | 1 | $11 |
How this compares
$3,535 in reported general payments places this provider in the 85th percentile of 2,237 adult health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 65 | $64,076 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 50 | $56,675 |
| OzempicSemaglutide | 34 | $50,364 |
| JardianceEmpagliflozin | 38 | $38,698 |
| MounjaroTirzepatide | 30 | $28,600 |
| TrulicityDulaglutide | 21 | $22,528 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 26 | $22,388 |
| EntrestoSacubitril/Valsartan | 16 | $20,742 |
| FarxigaDapagliflozin Propanediol | 21 | $14,552 |
| LinzessLinaclotide | 11 | $14,321 |
| TrintellixVortioxetine Hydrobromide | 12 | $14,297 |
| MyrbetriqMirabegron | 18 | $14,051 |
| Tresiba Flextouch U-200Insulin Degludec | 11 | $14,004 |
| SymbicortBudesonide/Formoterol Fumarate | 23 | $8,617 |
| Omeprazole | 364 | $7,197 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $152 | $64,07665 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $228 | $62,01363 claims |
| Lilly USA, LLCMounjaro, Trulicity | $326 | $51,12951 claims |
| Novo NordiskOzempic | $788 | $50,36434 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Symbicort | $149 | $45,55770 claims |
| Boehringer IngelheimJardiance | $116 | $38,69838 claims |
| NovartisEntresto | $128 | $20,74216 claims |
| AbbVieLinzess, Synthroid | $144 | $16,49036 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $97 | $14,29712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,237 adult health providers in Florida.
Other adult health in Perry
- Patricia PagnottaMaitland$441K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
- Alejandro Dela CruzOrlando$44K
- Cynthia OteroMaitland$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.